Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8120958 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Conditions: Melanoma;   Neoplasm Metastasis
Interventions: Drug: GP100 peptide;   Drug: IL-2
2 Completed Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: Interleukin-2

Study has passed its completion date and status has not been verified in more than two years.